The Cancer Genome Anatomy Project: EST Sequencing and the Genetics of Cancer Progression

Neoplasia

Volumn 1, Issue 2, 1999, Pages 101-106

  Krizman, David B ^a,b   Wagner, Lukas ^c   Lash, Alex ^c   Strausberg, Robert L ^a   Emmert Buck, Michael R ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE COURSE; EXPRESSED SEQUENCE TAG; FACTUAL DATABASE; GENETICS; HEALTH CARE ORGANIZATION; HUMAN; INTERNET; NEOPLASM; PATHOLOGY; REVIEW; UNITED STATES;

DATABASES, FACTUAL; DISEASE PROGRESSION; EXPRESSED SEQUENCE TAGS; HUMANS; INTERNET; NATIONAL INSTITUTES OF HEALTH (U.S.); NEOPLASMS; UNITED STATES;

EID: 0033139487     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.neo.7900002     Document Type: Review

References (24)

1. Strausberg RL, Dahl CA, and Klausner RD (1997). New opportunities for uncovering the molecular basis of cancer. Nat Genet 16, 415-516.
2. Boguski MS, Lowe TM, and Tolstoshev CM (1993). dbEST-database for "expressed sequence tags." Nat Genet 4, 332-333.
3. Lennon G, Auffray C, Polymeropoulos M, and Soares MB (1996). The I.M.A.G.E. Consortium: An integrated molecular analysis of genomes and their expression. Genomics 33, 151-152.
4. Boguski M, and Schuler G (1995). ESTablishing a human transcript map. Nat Gen 10, 369-371.
5. Schuler G (1997). Pieces of the puzzle: Expressed sequence tags and the catalog of human genes. J Mol Med 75, 694-698.
6. Hudson TJ, Stein LD, Gerety SS, Ma J, Castle AB, Silva J, Slonim DK, Baptista R, Kruglyak L, Xu SH, et al (1995). An STS-based map of the human genome. Science 270, 1945-1954.
7. Gyapay G, Schmitt K, Fizames C, Jones H, Vega-Czarny N, Spillett D, Muselet D, Prud'Homme JF, Dib C, Auffray C, Morissette J, Weissenbach J, and Goodfellow PN (1996). A radiation hybrid map of the human genome. Hum Mol Genet 5, 339-346.
8. Schuler GD, Boguski MS, Stewart EA, Stein LD, Gyapay G, Rice K, White RE, Rodriguez-Tome P, Aggarwal A, Bajorek E, Bentolila S, Birren BB, Butler A, Castle AB, Chiannilkulchai N, Chu A, Clee C, Cowles S, Day PJ, Dibling T, Drouot N, Dunham I, Duprat S, East C, Hudson TJ, et al (1996). A gene map of the human genome. Science 274, 540-546.
9. Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tomé P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M-T, Birren BB, et al (1998). A physical map of 30,000 human genes. Science 282, 744-746.
10. Mitelman F, Mertens F, and Johansson B (1997). A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15, 417-474.
11. Murphy GP, Busch C, Abrahamsson PA, Epstein JI, McNeal JE, Miller GJ, Mostofi FK, Nagle RB, Nordling S, Parkinson C, et al (1994). Histopathology of localized prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Scand J Urol Nephrol 162, [Suppl] 7-42.
12. Epstein JI (1996). Pathologic evaluation of prostatic carcinoma: critical information for the oncologist. Oncology 10, 527-534.
13. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, and Liotta LA (1996). Laser Capture Microdissection. Science 274, 998-1001.
14. Bonner RF, Emmert-Buck M, Cole K, Pohida T, Chuaqui R, Goldstein S, and Liotta LA (1997). Laser Capture Microdissection: Molecular analysis of tissue. Science 278, 1481-1483.
15. Krizman DB, Chuaqui RF, Meltzer PS, Trent JM, Duray PH, Linehan WM, Liotta LA, and Emmert-Buck MR (1996). Construction of a representative cDNA library from prostatic intraepithelial neoplasia (PIN). Cancer Res 56, 5380-5383.
16. Peterson LA, Brown M, Carlisle AJ, Kohn E, Liotta LA, Emmert-Buck MR, and Krizman DB (1998). An improved method for microdissected cDNA libraries using papillary serous ovarian carcinoma cells. Cancer Res 58, 5326-5328.
17. Seigel S (1956) Nonparametric Statistics for the Behavioral Sciences, McGraw-Hill, New York.
18. Heeb MJ, and Espana F (1998). Alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein. Blood Cells Mol Dis 24, 412-419.
19. Saedi MS, Hill TM, Kuus-Reichel K, Kumar A, Payne J, Mikolajczyk SD, Wolfert RL, and Rittenhouse HG (1998). The precursor form of the human kallikrein 2, a kallikrein homologous to prostate-specific antigen, is present in human sera and is increased in prostate cancer and benign prostatic hyperplasia. Clin Chem 44, 2115-2119.
20. Tsurusaki T, Koji T, Sakai H, Kanetake H, Nakane PK, and Saito Y (1998). Cellular expression of beta-microseminoprotein (beta-MSP) mRNA and its protein in untreated prostate cancer. Prostate 35, 109-116.
21. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, and Saito Y (1993). Beta-microseminoprotein immuno-reactivity as a new prognostic indicator of prostatic carcinoma. Prostate 22, 347-355.
22. Vasmatzis G, Essand M, Brinkmann U, Lee B, and Pastan I (1998). Discovery of three genes specifically expressed in human prostate by expressed sequence tag database analysis. Proc Natl Acad Sci USA 95, 300-304.
23. Brinkmann U, Vasmatzis G, Lee B, Yerushalmi N, Essand M, and Pastan I (1998). PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus. Proc Natl Acad Sci USA 95, 10757-10762.
24. Velculescu VE, Zhang L, Vogelstein B, and Kinzler KW (1995). Serial analysis of gene expression. Science 270, 484-487.